CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.

Thangavadivel, S; Zelle-Rieser, C; Olivier, A; Postert, B; Untergasser, G; Kern, J; Brunner, A; Gunsilius, E; Biedermann, R; Hajek, R; Pour, L; Willenbacher, W; Greil, R; Jöhrer, K; Oncotarget. 2016; 7(48):78605-78618

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter

Zucchetto, A; Tissino, E; Hartmann, TN; Chigaev, A; Del Poeta, G; Colombatti, A; Gattei, V CLIN CANCER RES. 2016; 22(13): 3410-3411.

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.

Zielinski, C; Láng, I; Inbar, M; Kahán, Z; Greil, R; Beslija, S; Stemmer, SM; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Petruzelka, L; Eniu, A; Nisenbaum, B; Dank, M; Anghel, R; Messinger, D; Brodowicz, T; Lancet Oncol. 2016; 17(9):1230-1239

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.

Kocher, T; Asslaber, D; Zaborsky, N; Flenady, S; Denk, U; Reinthaler, P; Ablinger, M; Geisberger, R; Bauer, JW; Seiffert, M; Hartmann, TN; Greil, R; Egle, A; Piñón Hofbauer, J; Leukemia. 2016; 30(6):1409-1413

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Pleyer, L; Valent, P; Greil, R; Int J Mol Sci. 2016; 17(7):

Immune checkpoint blockade in ovarian cancer.

Weiss, L; Huemer, F; Mlineritsch, B; Greil, R; Memo. 2016; 9:82-84

CDK4/6 inhibition in luminal breast cancer.

Gampenrieder, SP; Rinnerthaler, G; Greil, R; Memo. 2016; 9:76-81

Adjuvant medical treatment for breast cancer in elderly and old women

Westphal, T; Rinnerthaler, G; Mlineritsch, B MEMO-MAG EUR MED ONC. 2016; 9(1): 17-19.

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R; J Hematol Oncol. 2016; 9:39

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.

Ganghammer, S; Gutjahr, J; Hutterer, E; Krenn, PW; Pucher, S; Zelle-Rieser, C; Jöhrer, K; Wijtmans, M; Leurs, R; Smit, MJ; Gattei, V; Greil, R; Hartmann, TN; Haematologica. 2016; 101(3):e99-102